A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 24 Weeks in Participants With Eosinophilic Asthma (EXHALE-4)
Vancouver Coastal Health Research Institute (VCHRI) is proud to support future research leaders with the Top Graduating Doctoral Student Awards and the Rising Star Awards. These awards recognize the outstanding efforts of VCHRI trainees whose pursuit of research has made them exceptional role models and significant contributors to the Vancouver Coastal Health and University of British Columbia research community.
The 2024 Top Graduating Doctoral Student Award recipients are:
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eosinophilic Asthma
Extreme weather events are becoming more common due to climate change and causing significant impacts to the health and well-being of British Columbians. In 2021, an unprecedented heat dome led to 526 heat-related deaths, with 96 per cent occurring in residential settings. With the changing climate comes a crucial need for people to prepare for severe weather conditions and know where to access support.
In July 2024, Vancouver Coastal Health Research Institute researcher Dr. Brian Kwon was appointed the new director of the International Collaboration on Repair Discoveries (ICORD). Kwon first began studying as a PhD student at what was originally known as “CORD” in 2000.
Using artificial intelligence (AI) to spot patterns across thousands of cancer cell images, researchers at the Vancouver Coastal Health Research Institute have pinpointed a distinct subset of endometrial cancer that puts patients at much greater risk of recurrence and death, but would otherwise go unrecognized by traditional pathology and molecular diagnostics.
